Table 2.

Number of women who would have been appropriately treated, appropriately not treated, missed or over-treated for CIN 2+ vs. point-of-care detection method.

		True Positives Number of Women with CIN2+ Diagnosed and Appropriately Treated (out of 28 women total with CIN2+)	False Negatives Number of Women with CIN2+ Missed (out of 28 women total with CIN2+)	False Positives Number of Women Over-treated (out of 1688 women without CIN2+)	True Negatives Number of Women Appropriately Not Treated (out of 1688 women without CIN2+)	Number of Women who Received Appropriate Care (out of 1716 women)
Screening Test	Triage Test
HPV	-	23 (82%)	5 (18%)	162 (10%)	1526 (90%)	1549 (90%)
VIA	-	21 (75%)	7 (25%)	323 (19%)	1365 (81%)	1386 (81%)
HPV	VIA	19 (68%)	9 (32%)	63 (4%)	1625 (96%)	1644 (96%)
HPV	HRME	16 (57%)	12 (43%)	43 (3%)	1645 (97%)	1661 (97%)
VIA	HRME	14 (50%)	14 (50%)	124 (7%)	1564 (93%)	1578 (92%)